Related Experiment Videos
MIB1 (Ki-67) expression in non-Hodgkin's lymphomas
A Kalogeraki1, M Tzardi, I Panagiotides
1Department of Pathology University Hospital of Heraklion, Venizelion Hospital of Heraklion, Athens, Greece.
Insights
The MIB1 antibody reveals higher cell proliferation in high-grade non-Hodgkin
Area of Science:
- Oncology
- Immunohistochemistry
- Cell Biology
Background:
- Non-Hodgkin's Lymphomas (NHL) are a diverse group of cancers.
- Accurate grading is crucial for predicting NHL behavior and guiding treatment.
- Cell proliferation markers can aid in NHL classification and prognostication.
Purpose of the Study:
- To investigate the utility of the MIB1 monoclonal antibody as a cell proliferation marker in non-Hodgkin's lymphomas.
- To compare MIB1 expression levels between high-grade and low-grade NHLs.
- To assess the potential of MIB1 index in predicting NHL biological behavior.
Main Methods:
- Immunohistochemistry was performed on formalin-fixed, paraffin-embedded lymph node biopsy specimens.
- 40 high-grade and 46 low-grade NHL cases, classified by the Kiel classification, were analyzed.
- MIB1 staining intensity and patterns were evaluated in all cases.
Main Results:
- All studied non-Hodgkin's lymphoma cases exhibited nuclear MIB1 staining.
- A statistically significant difference (P < 0.005) in MIB1 expression was observed between high-grade and low-grade NHLs.
- High-grade NHLs demonstrated a higher proliferation rate compared to low-grade NHLs, with notable variations within histological groups.
Conclusions:
- The MIB1 index is a valuable tool for assessing individual tumor proliferation rates in non-Hodgkin's lymphomas.
- MIB1 expression levels correlate significantly with NHL grade, distinguishing high- from low-grade tumors.
- MIB1 index holds potential as a prognostic parameter when combined with clinical and laboratory data for non-Hodgkin's lymphomas.
Abstract:
The MIB1 monoclonal antibody which is used as a marker of cell proliferation was studied by immunohistochemistry on formalin-fixed and paraffin embedded biopsy specimens of lymph nodes in 40 high- and 46 lowgrade cases of non-Hodgkin's lymphomas (NHL) classified according to the Kiel classification. All cases were found to display nuclear MIB1 staining. A statistically significant difference (P < 0.005) was found between high- and low grade NHLs and this indicates that the high- grade NHL display a higher proliferation rate than low grade. In addition, remarkable variations in MIB1 expression were found among individual cases of the same histological group. These data may suggest that MIB1 index can help in the individual approach of the proliferation rate of each tumour and this may be an important parameter in association with clinical and other laboratory parameters for predicting the biological behaviour of non-Hodgkin's lymphomas.